Articles by Jeffrey L. Cummings (4)

Commentary on `A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.` Establishing a national biomarker database: Utility and incentives

Jeffrey L. Cummings

Alzheimer`s & Dementia 5 ( 2 ): 108 - 113 , 2009

Defining and labeling disease-modifying treatments for Alzheimer's disease

Jeffrey L. Cummings

Alzheimer`s & Dementia 5 ( 5 ): 406 - 418 , 2009

[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies

Zuzana Walker and Jeffrey L. Cummings

Alzheimer`s & Dementia 8 ( 1 ): 74 - 83 , 2012

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)

Adam L. Boxer, Michael Gold, Edward Huey, William T. Hu, Howard Rosen, Joel Kramer, Fen-Biao Gao, Edward A. Burton, Tiffany Chow, Aimee Kao, Blair R. Leavitt, Bruce Lamb, Megan Grether, David Knopman, David Knopman, Ian R. Mackenzie, Laura Mitic, Erik D. Roberson, Daniel Van Kammen, Marc Cantillon, Kathleen Zahs, George Jackson, Stephen Salloway, John Morris, Gary Tong, Howard Feldman, Howard Fillit, Susan Dickinson, Zaven S. Khachaturian, Margaret Sutherland, Susan Abushakra, Joseph Lewcock, Robert Farese, Robert O. Kenet, Frank LaFerla, Steve Perrin, Steve Whitaker, Lawrence Honig, Marsel M. Mesulam, Brad Boeve, Murray Grossman, Bruce L. Miller and Jeffrey L. Cummings

Alzheimer`s & Dementia 9 ( 2 ): 189 - 198 , 2013

Do you have a suggestion for journals

Suggest Journal